Scientists at Carnegie Mellon University received 28.5 million dollars from the Advanced Research Projects Agency for Health in January 2026 to develop functional 3D bioprinted liver tissue that could revolutionize treatment for acute liver failure and potentially end the transplant crisis affecting over 100,000 Americans currently waiting for organs. The